At the initiative of the international consortium IMACS (International Myositis Assessment and Clinical Studies Group), experts in adult idiopathic inflammatory myopathies have drawn up recommendations designed to improve cancer screening in this type of disease:
- online surveys combined with a Delphi-type methodology served as the basis for the experts’ deliberations,
- cancer risk stratification and screening methods were the main issues addressed,
- 18 recommendations were drawn up in these three areas, with the emphasis on the need to identify the groups most at risk according to the type of myositis and immunological status.
Thanks to this guide, clinicians will be able to identify malignant tumours earlier and improve their patients’ survival accordingly.
